ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE) Trial

Northwestern University will be responsible for conducting the ADVISE Trial according to ICH Good Clinical Practice Guidelines, which includes obtaining appropriate regulatory approvals; completing study personnel and clinic certification, following the procedures described in the study protocol for evaluation, enrollment, treatment, and follow-up of study subjects; expedited reporting of urgent safety matters to CC; ensuring that subjects’ Protected Health Information remains confidential; and that study data are accurate, complete, and submitted to the CC in a timely manner.